Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$24.60 – $31.82
41% from low
Exchange
OTC Link
OS
ROYAL PHILLIPS NV ORD
No one on the platform currently holds RYLPF.
No tracked institution reports a position in RYLPF as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-05-13 | $0.8500 | 2026-06-03 |
| 2025-05-13 | $0.8500 | 2025-06-06 |
| Execution date | Ratio |
|---|---|
| 2026-05-13 | 27.9341-for-26.9341 |
| 2025-05-13 | 24.6353-for-23.6353 |
| 2024-05-09 | 30.2684-for-29.2684 |
| 2023-05-11 | 23.3906-for-22.3906 |
| 2020-06-30 | 50.2971-for-49.2971 |
No one on the platform has traded RYLPF yet.
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $18.1B | +1.9% | $1.64 | $1.62–$1.66 | 16.9× | 1 |
| 2027 | $18.9B | +4.4% | $1.68 | $1.67–$1.70 | 16.4× | 1 |
| 2028 | $19.7B | +4.4% | $1.91 | $1.90–$1.94 | 14.4× | 1 |
| 2029 | $20.5B | +4.3% | $2.01 | $2.00–$2.04 | 13.7× | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 3 of the last 7 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-07-27 | $0.40 | $0.56 | +39.4% |
| 2026-05-06 | $0.23 | $0.27 | +13.6% |
| 2026-02-10 | $0.56 | $0.70 | +25.0% |
| 2025-11-04 | $0.37 | $0.22 | -38.8% |
| 2025-07-29 | $0.32 | $0.30 | -6.6% |
| 2025-05-06 | $0.21 | $0.08 | -60.8% |
| 2024-10-28 | $0.43 | $0.21 | -50.9% |
| -3.66% |
| $39.5B |
| — |
| SDMHFSartorius Stedim Biotech S.A. | $208.48 | +3.67% | $20.3B | — |
| SDZNYSandoz Group AG | $89.81 | -0.94% | $38.9B | — |
Source: Financial Modeling Prep · peers by sector/industry